The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, L.
Right arrow Articles by Bothwell, A. L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, L.
Right arrow Articles by Bothwell, A. L. M.
The Journal of Immunology, 2004, 173: 3020-3026.
Copyright © 2004 by The American Association of Immunologists

Bcl-2 Transduction Protects Human Endothelial Cell Synthetic Microvessel Grafts from Allogeneic T Cells In Vivo1

Lian Zheng*, Thomas F. Gibson*, Jeffrey S. Schechner{dagger},{ddagger}, Jordan S. Pober*,{dagger},{ddagger} and Alfred L. M. Bothwell2,*,{dagger}

* Section of Immunobiology and {dagger} Interdepartmental Program in Vascular Biology and Transplantation, {ddagger} Departments of Dermatology and Pathology, Yale University School of Medicine, New Haven, CT 06520

T cell interactions with vascular endothelial cells (EC) are of central importance for immune surveillance of microbes and for pathological processes such as atherosclerosis, allograft rejection, and vasculitis. Animal (especially rodent) models incompletely predict human immune responses, in particular with regard to the immunological functions of EC, and in vitro models may not accurately reflect in vivo findings. In this study, we describe the development of an immunodeficient SCID/bg murine model combining a transplanted human synthetic microvascular bed with adoptive transfer of human T lymphocytes allogeneic to the cells of the graft that more fully recapitulates T cell responses in natural tissues. Using this model, we demonstrate that transduced Bcl-2 protein in the engrafted EC effectively prevents injury even as it enhances T cell graft infiltration and replication.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Suarez, B. R. Shepherd, D. A. Rao, and J. S. Pober
Alloimmunity to Human Endothelial Cells Derived from Cord Blood Progenitors
J. Immunol., December 1, 2007; 179(11): 7488 - 7496.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. R. Shepherd, D. R. Enis, F. Wang, Y. Suarez, J. S. Pober, and J. S. Schechner
Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells
FASEB J, August 1, 2006; 20(10): 1739 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. R. Enis, B. R. Shepherd, Y. Wang, A. Qasim, C. M. Shanahan, P. L. Weissberg, M. Kashgarian, J. S. Pober, and J. S. Schechner
Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells
PNAS, January 11, 2005; 102(2): 425 - 430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.